ClinicalTrials.Veeva

Menu

The Percentage of Cases of Acute Treatment With Allopurinol in Gout Patients

H

Hillel Yaffe Medical Center

Status

Unknown

Conditions

Gout

Treatments

Drug: Allopurinol

Study type

Interventional

Funder types

Other

Identifiers

NCT03601260
HYMC-FKH-1

Details and patient eligibility

About

The aim of the study is to determine the percentage of cases of acute treatment with Allopurinol in gout patients who have been previously treated.

Enrollment

700 estimated patients

Sex

All

Ages

25+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gout patients

Exclusion criteria

  • Pregnant women
  • Chronic renal failure
  • Patients with Allopurinal hypersensitivity

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

700 participants in 1 patient group

Gout Patients
Other group
Description:
Allopurinol 100 mg-300mg/day as secondary treatment in gout patients
Treatment:
Drug: Allopurinol

Trial contacts and locations

1

Loading...

Central trial contact

Fadi Khalaila, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems